BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marsh RDW, Baker M, Catenacci DV, Kozloff M, Polite BN, Posner MC, Roggin KK, Talamonti MS, Kindler HL. Peri-operative modified FOLFIRINOX (mFOLFIRINOX) in resectable pancreatic cancer (PDAC): A pilot study. JCO 2016;34:312-312. [DOI: 10.1200/jco.2016.34.4_suppl.312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Vidri RJ, Vogt AO, Macgillivray DC, Bristol IJ, Fitzgerald TL. Better Defining the Role of Total Neoadjuvant Radiation: Changing Paradigms in Locally Advanced Pancreatic Cancer. Ann Surg Oncol 2019;26:3701-8. [DOI: 10.1245/s10434-019-07584-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220 [PMID: 30147847 DOI: 10.4251/wjgo.v10.i8.211] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]